Projects per year
- 150 - 200 out of 2,056 results
Search results
-
An Open-Label Phase I Study of Lipoteichoic Acid LTA-T in Patients with Advanced and/or Metastatic Solid Tumours
Johnson, P.
1/06/01 → 31/05/03
Project: Research
-
An Open Phase 1 Study To Assess The Bioavailibility Of A 250mg Single Dose Of ZD1839 In Patients With Solid Tumours.
Johnson, P.
1/03/01 → 31/12/03
Project: Industry
-
A novel animal model to explore the whole organism response to 21-hydroxylase deficiency
Krone, N. & Zaucker, A.
1/09/15 → 31/08/16
Project: Research
-
A novel gamma delta T cell platform technology to enable drug-tunable targeting of CAR tumour associated antigen targets
Lee, S. & Willcox, B.
3/04/17 → 2/10/19
Project: Research
-
A Novel Method to Track Epigenetic Transmission at the Start of Development
1/09/21 → 31/08/24
Project: Research
-
A novel platform for rapid sequence enrichment prior to clinical NGS
Griffiths, M. & Wallis, Y.
1/10/13 → 31/05/15
Project: Other Government Departments
-
A Novel Prognostic Model for Colorectal Cancer Using Bioinformatics Technology
Grumett, S.
4/12/00 → 3/12/03
Project: Research Councils
-
A Phase 11 Multi-Dose Study of SGN-30 in Patients with Refractory or Recruitment Hogkin's Disease.
Mahendra, P.
Queen Elizabeth Hospital Birmingham
1/01/06 → 31/12/07
Project: Research
-
A phase 11 Non randomised Study of Modrenal in Pre-menopausal Women with Advanced Oestrogen Receptor Positive Breast Cancer who have relapsed or are refractory to Hormone Therapies of Tamoxifen, Goserelin & an Aromatase Inhib (Bioenvision).
Rea, D.
Queen Elizabeth Hospital Birmingham
1/06/05 → 30/04/07
Project: Research
-
A Phase 1b/2, Open-Label, Randomized Study of Sorafenib With or Without BIIB002 in Subjects With Advanced Hepatocellular Carcinoma
Johnson, P.
Queen Elizabeth Hospital Birmingham
1/01/10 → 31/08/12
Project: Research
-
A Phase 1b/2a, Multicentre, Randomised, Double-Blind, Parralel-Group, Placebo Controlled Study to Evaluate the Safety & Pharmacokinetics of Z-360 in Subjects with Unreasonable Advanced Pancreatic Cancer in Combination with Gemcitabine....
Palmer, D.
Queen Elizabeth Hospital Birmingham
1/01/06 → 30/06/10
Project: Research
-
A Phase 1B Clinical Trial of BKM120 with Bortezomib in Defned Genetic Subgroups of Patients with Relapsed or Refractory Multiple Myeloma
Fenwick, N.
NOVARTIS PHARMACEUTICALS UK LTD, Janssen-Cilag Limited
9/11/15 → 1/01/23
Project: Research
-
A Phase 1b Study of Eltromobopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders (ELAstic)
Fenwick, N.
Glaxosmithkline, CELGENE INTERNATIONAL SARL
1/10/14 → 30/09/21
Project: Research
-
A Phase 2, Randomised, Open-Label Study of Single Agent Azacitidine (Vidaza) vs. Single Agent MGCD0103 vs. Azacitidine in Combination With MGCD0103 for the treatment of Elderly Subjects With Newly Diagnosed Acute Myeloid Leukaemia or Interm
Craddock, C.
Queen Elizabeth Hospital Birmingham
1/04/08 → 31/12/12
Project: Research
-
A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T)
Siddique, S., Jackson, A. & Craddock, C.
6/07/17 → 31/12/24
Project: Industry
-
A Phase 2 Randomised, Double-blind, Placebo Controlled Multicentre Study of Orally Administered ATL-104 to Assess Safety & Tolerance & Effect on Oral Mucositis in Patients with Haematological Malignancies After Treatment with Chemotherapy..
Mahendra, P.
Queen Elizabeth Hospital Birmingham
28/07/04 → 27/06/06
Project: Research
-
A Phase 2 study of the anti-tumour activity and safety of Prolarix in hepatocellular carcinoma.
Palmer, D.
Queen Elizabeth Hospital Birmingham
1/02/09 → 31/01/11
Project: Research
-
A phase IA/II multicenter, dose-escalation study of oral AMN107 on a continuous daily dosing schedule in adult patients with Gleevec (imatinib)-resistant CML in accelerated phase or blast crisis, relapsed/refractory Ph+ ALL, and other hemat
Craddock, C.
Queen Elizabeth Hospital Birmingham
1/01/06 → 31/12/12
Project: Research
-
A Phase Ib/II, multi-center, open-label study to evaluate the efficacy of AUY922 in combination with Trastuzumab in patients with locally advanced or metastatic HER 2-positive breast cancer, that has progressed after or during at least one
Rea, D.
Queen Elizabeth Hospital Birmingham
1/02/11 → 31/01/15
Project: Research
-
A Phase II, Open-Label, Randomised, Comparative, Multicentre Study to Compare the Efficacy and tolerability of Oral Olaparib in Combination with Carboplatin and Paclitaxel Versus Carboplatin and Paclitaxel Alone in Patients with Platinum...
Williams, S.
Sandwell & West Birmingham Hospitals
1/04/10 → 31/12/13
Project: Research
-
A Phase II, Open-Label, Randomized, Multicentre Trial of GW786034(Pazopanib) in combination with Lapatinib (GW572016) compared to Lapatnib alone as first line of Therapy in Subjects with Advanced or Metastatic Breast Cancer with ErbB2 Fluor
Rea, D.
Queen Elizabeth Hospital Birmingham
1/01/07 → 30/06/09
Project: Research
-
A Phase II, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Centre Study To Assess the Activity Of Once-Daily Orally Administered ZD4054 15MG and 10MG Doses On Bone Metastases In Pain-Free Or Mildly Systematic Patients..
Queen Elizabeth Hospital Birmingham
1/01/05 → 31/12/07
Project: Research
-
A Phase II, Randomised, Double-blind, Parallel Group Study to Assess the Efficacy of AZD2171 45mg Versus Placebo following 12 Weeks of Treatment in Patients with Metastatic or Recurrent Renal Cell Carcinoma who have had no Previous Anti-VE
Porfiri, E.
Queen Elizabeth Hospital Birmingham
14/11/06 → 31/07/12
Project: Research
-
A Phase III Extension Study To Evaluate The Safety Of 10mg Atrasentan In Men With Hormone-Refractory Prostate Cancer.
1/01/02 → 31/12/05
Project: Industry
-
A Phase III Randomised Trial of CMF v Sequential Doxorubicin followed by CMF in Women Receiving Adjuvant Chemotherapy for Early Breast Cancer
Young, L. & Johnson, P.
1/01/99 → 31/12/03
Project: Research
-
A Phase III Study of Sequential v.Synchronous Chemotherapyand Radiotherapy in the Adjuvant Treatment of Early Breast Cancer (SECRAB)
Fernando, I.
1/03/98 → 31/05/05
Project: Research
-
A Phase II pilot safety and tolerability study of ILB in patients with Motor Neurone Disease (MND)/ Amyotrophic Lateral Sclerosis(ALS)
Logan, A., Bach, S., Barton, D., Brock, K. & Smith, D.
1/06/18 → 20/08/23
Project: EU
-
A Phase II Randomised Study Of BAY-43-9006 In Patients With Unresectable And/Or Metastatic Renal Cancer (Bayer)
Porfiri, E.
Queen Elizabeth Hospital Birmingham
1/09/04 → 31/08/08
Project: Research
-
A Phase II Study To Determine The Biological Effects OfBispecific Antibody MDX H210 (520c9xh22).
1/08/96 → 31/12/00
Project: Research
-
A phase II trial of MK-3475 in patients with non-small cell lung cancer with a performance status of 2 (PePS2)
Billingham, L. & Middleton, G.
21/10/15 → 31/12/24
Project: Industry
-
A phase II trial to assess the activity of Gemtuzumab Ozogamicin Therapy in HAemophagocytic lymphohistiocytosis (HLH) or Macrophage activation syndrome (MAS) or relapsed/refractory solid tumours
De Santo, C., Kearns, P., Billingham, L., Middleton, G. & Mussai, F.
Little Princess Trust, Eveson Charitable Trust
1/01/20 → 31/12/24
Project: Research
-
A Phase I Trial of NECTAR: Nelarabine, Etoposide, Cyclophosphamide in T-ALL Relapse
Erasmus Univesitair Medisch Centrum, BLOODWISE
4/11/13 → 3/01/21
Project: Research